Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Elicio Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immix Biopharma Inc. May 22, 202699.7%
-
Immix Biopharma Inc. June 20, 202599.7%
-
Immix Biopharma Inc. June 11, 202498.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 22, 2026 | Immix Biopharma Inc. | Grant or award | +6,250 | — | — |
| Mar 5, 2025 | Elicio Therapeutics Inc. | Derivative conversion | +3,500,573 | $5.81 | $20,338,329 |
| Dec 22, 2023 | Elicio Therapeutics Inc. | Open-market purchase | +1,213,000 | $5.81 | $7,047,530 |
Questions about Yekaterina Chudnovsky
What boards is Yekaterina Chudnovsky on?
Yekaterina Chudnovsky sits on the boards of Elicio Therapeutics Inc. and Immix Biopharma Inc.
How long has Yekaterina Chudnovsky served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.